{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T09:03:12Z","timestamp":1784710992815,"version":"3.55.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,22]]},"DOI":"10.7759\/cureus.113142","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T08:34:02Z","timestamp":1784709242000},"source":"Crossref","is-referenced-by-count":0,"title":["Characterization of High-Grade Glial and Related Neuroepithelial Tumors Using the AOSNP-ADAPTR Framework: A Case Series With Review of Literature"],"prefix":"10.7759","author":[{"given":"Soumyanil","family":"Pandey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alka","family":"Dixit Vats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adreena","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/ajns.AJNS_377_20","article-title":"Clinicopathological correlation of glioma patients with respect to immunohistochemistry markers: a prospective study of 115 patients in a tertiary care hospital in North India","volume":"16","author":"Dahuja G","year":"2021","unstructured":"Dahuja G, Gupta A, Jindal A, Jain G, Sharma S, Kumar A. Clinicopathological correlation of glioma patients with respect to immunohistochemistry markers: a prospective study of 115 patients in a tertiary care hospital in North India. Asian J Neurosurg. 2021, 16:732-7. 10.4103\/ajns.AJNS_377_20","journal-title":"Asian J Neurosurg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.18203\/2349-2902.isj20203792","article-title":"A single-centre observational study of 124 surgically managed glioma patients: molecular subtyping and its correlation with clinico-radiological profile","volume":"7","author":"Singh A","year":"2020","unstructured":"Singh A, Singh S, Agrawal S, et al.. A single-centre observational study of 124 surgically managed glioma patients: molecular subtyping and its correlation with clinico-radiological profile. Int Surg J. 2020, 7:3047-55. 10.18203\/2349-2902.isj20203792","journal-title":"Int Surg J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9070799","article-title":"IDH mutations in glioma: double-edged sword in clinical applications?","volume":"9","author":"Kayabolen A","year":"2021","unstructured":"Kayabolen A, Yilmaz E, Bagci-Onder T. IDH mutations in glioma: double-edged sword in clinical applications?. Biomedicines. 2021, 9:799. 10.3390\/biomedicines9070799","journal-title":"Biomedicines"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-017-0311-6","article-title":"Molecular subgroups of glioblastoma - an assessment by immunohistochemical markers","volume":"25","author":"Nagy \u00c1","year":"2019","unstructured":"Nagy \u00c1, Garzuly F, Pad\u00e1nyi G, et al.. Molecular subgroups of glioblastoma - an assessment by immunohistochemical markers. Pathol Oncol Res. 2019, 25:21-31. 10.1007\/s12253-017-0311-6","journal-title":"Pathol Oncol Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-023-04250-5","article-title":"Updates on the WHO diagnosis of IDH-mutant glioma","volume":"162","author":"Reuss DE","year":"2023","unstructured":"Reuss DE. Updates on the WHO diagnosis of IDH-mutant glioma. J Neurooncol. 2023, 162:461-9. 10.1007\/s11060-023-04250-5","journal-title":"J Neurooncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S397550","article-title":"Immunohistochemical expression of IDH1, ATRX, Ki67, GFAP, and prognosis in Indonesian glioma patients","volume":"16","author":"Priambada D","year":"2023","unstructured":"Priambada D, Thohar Arifin M, Saputro A, et al.. Immunohistochemical expression of IDH1, ATRX, Ki67, GFAP, and prognosis in Indonesian glioma patients. Int J Gen Med. 2023, 16:393-403. 10.2147\/IJGM.S397550","journal-title":"Int J Gen Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5114\/fn.2022.118183","article-title":"WHO CNS5 2021 classification of gliomas: a\u00a0practical review and road signs for diagnosing pathologists and proper patho-clinical and neuro-oncological cooperation","volume":"60","author":"Sejda A","year":"2022","unstructured":"Sejda A, Grajkowska W, Trubicka J, et al.. WHO CNS5 2021 classification of gliomas: a\u00a0practical review and road signs for diagnosing pathologists and proper patho-clinical and neuro-oncological cooperation. Folia Neuropathol. 2022, 60:137-52. 10.5114\/fn.2022.118183","journal-title":"Folia Neuropathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1131642","article-title":"Clinical updates on gliomas and implications of the 5th edition of the WHO classification of central nervous system tumors","volume":"13","author":"Guo X","year":"2023","unstructured":"Guo X, Shi Y, Liu D, et al.. Clinical updates on gliomas and implications of the 5th edition of the WHO classification of central nervous system tumors. Front Oncol. 2023, 13:1131642. 10.3389\/fonc.2023.1131642","journal-title":"Front Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s10014-022-00428-3","article-title":"The 2021 WHO classification of tumors, 5th edition, central nervous system tumors: the 10 basic principles","volume":"39","author":"Komori T","year":"2022","unstructured":"Komori T. The 2021 WHO classification of tumors, 5th edition, central nervous system tumors: the 10 basic principles. Brain Tumor Pathol. 2022, 39:47-50. 10.1007\/s10014-022-00428-3","journal-title":"Brain Tumor Pathol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13062","article-title":"Classification of adult-type diffuse gliomas: impact of the World Health Organization 2021 update","volume":"32","author":"Whitfield BT","year":"2022","unstructured":"Whitfield BT, Huse JT. Classification of adult-type diffuse gliomas: impact of the World Health Organization 2021 update. Brain Pathol. 2022, 32:13062. 10.1111\/bpa.13062","journal-title":"Brain Pathol"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.18410\/jebmh\/2016\/496","article-title":"Histopathological spectrum and grading of CNS tumours in tertiary centre: case study of 83 cases","volume":"3","author":"Sumathi V","year":"2016","unstructured":"Sumathi V, Balakrishnan K, Krishna MS, Maheshwari KU. Histopathological spectrum and grading of CNS tumours in tertiary centre: case study of 83 cases. J Evid Based Med Healthc. 2016, 3:2240-3.","journal-title":"J Evid Based Med Healthc"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5455\/ijmsph.2019.0616504062019","article-title":"Histopathological spectrum of brain tumors: a 4-year retrospective study from a single tertiary care facility","volume":"8","author":"Hamdani SM","year":"2019","unstructured":"Hamdani SM, Dar NQ, Reshi R. Histopathological spectrum of brain tumors: a 4-year retrospective study from a single tertiary care facility. Int J Med Sci Public Health. 2019, 8:673-6. 10.5455\/ijmsph.2019.0616504062019","journal-title":"Int J Med Sci Public Health"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3329\/bjms.v13i3.19148","article-title":"Analysis of brain tumors in Kashmir Valley - a 10 year study","volume":"13","author":"Dhar A","year":"2014","unstructured":"Dhar A, Bhat AR, Nizami FA, et al.. Analysis of brain tumors in Kashmir Valley - a 10 year study. Bangladesh J Med Sci. 2014, 13:268-77. 10.3329\/bjms.v13i3.19148","journal-title":"Bangladesh J Med Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.5455\/ijmsph.2014.080720141","article-title":"Retrospective histological analysis of CNS tumors - a 5 year study","volume":"3","author":"Ghanghoria S","year":"2014","unstructured":"Ghanghoria S, Mehar R, Kulkarni CV, Mittal M, Yadav A, Patidar H. Retrospective histological analysis of CNS tumors - a 5 year study. Int J Med Sci Public Health. 2014, 3:1205-7. 10.5455\/ijmsph.2014.080720141","journal-title":"Int J Med Sci Public Health"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPZOIY3WY4KIKE","article-title":"IDH1 mutations in diffusely infiltrating astrocytomas: grade specificity, association with protein expression, and clinical relevance","volume":"138","author":"Thota B","year":"2012","unstructured":"Thota B, Shukla SK, Srividya MR, et al.. IDH1 mutations in diffusely infiltrating astrocytomas: grade specificity, association with protein expression, and clinical relevance. Am J Clin Pathol. 2012, 138:177-84. 10.1309\/AJCPZOIY3WY4KIKE","journal-title":"Am J Clin Pathol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-016-0331-6","article-title":"ATRX immunostaining predicts IDH and H3F3A status in gliomas","volume":"4","author":"Ebrahimi A","year":"2016","unstructured":"Ebrahimi A, Skardelly M, Bonzheim I, et al.. ATRX immunostaining predicts IDH and H3F3A status in gliomas. Acta Neuropathol Commun. 2016, 4:60. 10.1186\/s40478-016-0331-6","journal-title":"Acta Neuropathol Commun"},{"key":"ref17","article-title":"Gliomas: correlation of histologic grade, Ki67 and p53 expression with patient survival","volume":"11","author":"Arshad H","year":"2010","unstructured":"Arshad H, Ahmad Z, Hasan SH. Gliomas: correlation of histologic grade, Ki67 and p53 expression with patient survival. Asian Pac J Cancer Prev. 2010, 11:1637-40.","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-95958-9","article-title":"Prognostic role of Ki-67 in glioblastomas excluding contribution from non-neoplastic cells","volume":"11","author":"Dahlrot RH","year":"2021","unstructured":"Dahlrot RH, Bangs\u00f8 JA, Petersen JK, et al.. Prognostic role of Ki-67 in glioblastomas excluding contribution from non-neoplastic cells. Sci Rep. 2021, 11:17918. 10.1038\/s41598-021-95958-9","journal-title":"Sci Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/509399-characterization-of-high-grade-glial-and-related-neuroepithelial-tumors-using-the-aosnp-adaptr-framework-a-case-series-with-review-of-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T08:34:03Z","timestamp":1784709243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/509399-characterization-of-high-grade-glial-and-related-neuroepithelial-tumors-using-the-aosnp-adaptr-framework-a-case-series-with-review-of-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.113142","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,22]]}}}